Blog: Spirit of Money, Financial Fluidity
by munificent

Nasdaq, brew of choice?

Can it be only money? 400k is a drop in the bucket for Schwab, I'm curious to read a posting that hinted some had been asked to leave the NYSE-this is rare unless there has been aggregious offenses of rules and reg's. It usually is not a casual parting!

Date:   1/5/2006 5:44:07 AM   ( 18 y ) ... viewed 1647 times

Battle of the Brands: NYSE and Nasdaq

''The competition for the attention of CFOs and management should be a big winner'' for companies, says one observer.

Helen Shaw, CFO.com
January 05, 2006

A half-dozen centuries ago, a competitor who "entered the lists" was riding onto a mock battleground — the site of jousting and other deeds of arms. Today, a "listings" battle is being contested not merely between corporate worthies, but between the venues themselves.

The decisions by Charles Schwab Corp. and Cadence Design Systems Inc. to drop themselves from the New York Stock Exchange and list solely on the Nasdaq Stock Market are just two recent maneuvers in a long-running rivalry — one that promises good news for corporate issuers.

"The competition for the attention of CFOs and management should be a big winner" for companies, says Jamie Selway, founder and managing director of brokerage White Cap Trading. Selway believes that the NYSE and Nasdaq — which derive roughly one-third of their revenues from listing fees — will continue to introduce trading-technology enhancements and value-added services.

Both the NYSE and Nasdaq maintain that companies should regularly review their listing decision. "To the extent that Corporate America chooses not to do that, it leads to an unhealthy situation," says Robert Greifeld, president and chief executive officer of Nasdaq. "The implicit cost to investors of markets that do not take advantage of developing technology affects every trade." A spokesman for the NYSE stated that every company "has that duty to the shareholders to make sure they're listed on the right marketplace" and should evaluate it "in a way that benefits their shareholders the best."

Complicating that evaluation: Listing and trading are not necessarily linked. That's been more true than ever since last April, when the Securities and Exchange Commission passed an amendment to the "trade-through rule," part of Regulation National Market Structure. In simplest form, the amended rule requires that all investor trades be executed at the best price, even if stock markets must fill the order through a competitor.

Not long after the passage of the trade-through rule, Nasdaq revealed that it intended to purchase the electronic trading network of Instinet Group Inc., a deal that was completed in December. Likewise, in April the NYSE announced the proposed acquisition of Chicago-based electronic market Archipelago; Big Board members and Archipelago shareholders gave their approval last month.

Schwab and Cadence were early participants in Nasdaq's dual-listing program, launched in January 2004. The program now includes Apache Corp., Hewlett-Packard Co., Walgreen Co., American Financial Group, Chicago Mercantile Exchange Holdings Inc., and the Nuveen Equity Premium Advantage Fund of Nuveen Investments Inc. (though not the company itself).

Bill Porter, the chief financial officer at Cadence, says it was difficult to compare the merits of the NYSE and Nasdaq while his company was dual-listed. One reason for the difficulty, suggests White Cap's Selway, is a provision under Reg NMS known as "unlisted trading privileges." UTPs enable other markets to trade NYSE stocks whether they are dual-listed or not — and indeed, for that reason the Big Board maintains that Nasdaq's dual-listing program has not improved effective spreads, investor choice, or other aspects of market quality for the participating companies.

(At present the NYSE, which maintains a specialist-based floor-trading system, traffics only in its own stocks, as well as the AMEX exchange-traded fund known as Spiders. When the NYSE's purchase of Archipelago is complete, however, the new company will be able to trade any stocks, including those of Nasdaq.)

Nonetheless, Cadence sorted through the myriad of statistics provided by each market while the company was dual-listed, and it noticed one definitive pattern: Large blocks of its shares traded outside the purview of the NYSE. Says Porter, "That confirmed for us that we were doing something our shareholders liked."

Likewise, according to Schwab spokesman Greg Gable, trading in the brokerage's shares increased on Nasdaq during the its time in the dual-listing program. Gable expects that listing solely on Nasdaq — the company made the move on December 20 — will offer shareholder benefits including greater liquidity, lower volatility, and better execution quality.

"We considered where each exchange was in terms of their electronic trading platforms," says Cadence's Porter. "For us, electronic trading was good, we could get it done less expensively, and there were some questions about why we would pay more" to list on the NYSE.

That cost can be a big consideration; Schwab will now spend $400,000 per year less in annual fees. On Nasdaq, listing fees range from about $25,000 to $75,000 per year, based on total shares outstanding, according to spokeswoman Bethany Sherman. The fee for an initial public offering or for a company moving its listing to Nasdaq, Sherman adds, averages a little over $100,000.


Add This Entry To Your CureZone Favorites!

Print this page
Email this page
DISCLAIMER / WARNING   Alert Webmaster


CureZone Newsletter is distributed in partnership with https://www.netatlantic.com


Contact Us - Advertise - Stats

Copyright 1999 - 2024  curezone.com

0.031 sec, (2)

Back to blog!
 
Add Blog To Favorites!
 
Add This Entry To Favorites!

Comments (20 of 53):
Re: All this tax b… faric 7 mon
Re: All this tax b… TomHi… 8 mon
Re: All this tax b… Kempa… 9 mon
Re: All this tax b… Kempa… 11 mon
Re: All this tax b… Kempa… 11 mon
Thanks for your in… kermi… 18 y
I wonder about wom… 9thbo… 18 y
everybody knows... drofin… 18 y
Taiwan/China Next? Rikki-… 18 y
I am sorry to hear… 9thbo… 19 y
Re: I have a retir… #4933… 19 y
Nope, I don't make… 9thbo… 19 y
commercial pitch mark777 19 y
oh well... drofinnah 19 y
Yes this may well … kermi… 19 y
First hand experie… 9thbo… 19 y
Depends on age/ris… 9thbo… 19 y
10% of portfolio i… #1923… 19 y
Hi K-! Hope all i… 9thbo… 19 y
WOW who would thin… kermi… 19 y
All Comments (53)

Blog Entries (12 of 249):
Nasdaq, brew of choice?  18 y
$750.00 an hour?  18 y
Yield Curve  18 y
CFO blog/China  18 y
Taiwan/China Next?  18 y
Dollar Bill Symbols  18 y RN
usd$$$  18 y
Recession-When/Why  19 y
Enron's exCFO to help Prosec…  19 y
5 smartest things on Wall St…  19 y
Exxon  19 y
Horse is Dead-  19 y
All Entries (249)

Blogs by munificent (10):
Yoga Path  18 y  (396)
Cold Water Blog  18 y  (269)
Quantum Intelligensia  18 y  (267)
Leadership  18 y  (67)
BaBaGee Blog  18 y  (16)
Breathwork  19 y  (16)
Desire  18 y  (5)
Sacred Sex  18 y  (4)
Apothegm  18 y  (3)
Breathwork for wholeness  19 y  (3)

Similar Blogs (10 of 185):
Political Sciences:…  by lukerobinson291  6 mon
Туl…  by Devvver  7 mon
Antonia Travel Blog  by anradeva  8 mon
Chef Jemichel ~ The…  by chef jem  9 mon
Canada Travel Blog  by opencities  9 mon
IT intern  by DataDynamoLucas  10 mon
yuridicheskoe  by surkov9977  11 mon
George’s Diary  by jeorgecolin  14 mon
Here is What You Ne…  by NoahCarr123  21 mon
How Can I get my Sp…  by John7035  21 mon
All Blogs (1,019)

Back to blog!
 

J.Crow’s® Lugol’s Iodine
Free S&H.Restore lost reserves.J.CROW’S®Lugol’s Iodine Solut...



Wormwood Capsules, Clove Tincture
Hulda Clark Parasite Cleanse